Page last updated: 2024-10-25

ciclopirox and Shock, Septic

ciclopirox has been researched along with Shock, Septic in 1 studies

Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.

Research Excerpts

ExcerptRelevanceReference
"Ciclopirox (CPX) is a broad-spectrum antimycotic agent which also exerts anti-inflammatory effects in human diseases."1.91Ciclopirox mitigates inflammatory response in LPS-induced septic shock via inactivation of SORT1-mediated wnt/β-Catenin signaling pathway. ( Chen, J; Deng, Y; He, Y; Li, X; Wang, W; Zhou, L, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhou, L1
He, Y1
Deng, Y1
Li, X1
Wang, W1
Chen, J1

Other Studies

1 other study available for ciclopirox and Shock, Septic

ArticleYear
Ciclopirox mitigates inflammatory response in LPS-induced septic shock via inactivation of SORT1-mediated wnt/β-Catenin signaling pathway.
    Immunopharmacology and immunotoxicology, 2023, Volume: 45, Issue:6

    Topics: Animals; beta Catenin; Ciclopirox; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbr

2023